Tibial Plateau Fractures
Conditions
Keywords
tibial plateau fracture
Brief summary
Subjects may receive an injection at the end of the surgery to fix their broken leg that may reduce their pain and hospital stay
Detailed description
Subjects will be randomized to bupivicaine or saline injection in the joint at the end of Open Reduction Internal Fixation of the tibial plateau fracture
Interventions
DRUGBupivacaine injection
Injection at end of Open Reduction Internal Fixation
OTHERSaline
Injection at end of Open Reduction Internal Fixation
Sponsors
University of Washington
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
Patient is asleep at time of injection
Intervention model description
Randomized Control Trial
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age \>=18 year , * tibial plateau fracture undergoing Open Reduction and fixation Exclusion: * allergy to bupivacaine * Prolonged external fixator use
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain in the knee visual analogue scale 11 point scale 0(no pain) -10 (worst pain) | From date of hospitalization to end of follow-up at 6 months | Pain at time of visit |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of stay for hospitalization | From date of hospitalization up to one month post surgery | Length of stay for hospitalization |
Contacts
Primary ContactJulie Agel
Outcome results
None listed